ALTAF PHARM LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-07-31 |
|---|---|
| Total assets | £7.3k |
| Current assets | £12.3k |
| Cash | £10.0k |
| Debtors | £2.4k |
| Net assets | £7.3k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (4 events)Click to expand
- 2025-12-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-07-11🏢Company incorporatedAs ALTAF PHARM LTD
- 2024-07-11➕ALTAF, Aroosa appointeddirector
- 2024-07-11📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "ALTAF" — strong identity link between founder and business.
- +Young company: Only 2.0 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Aroosa Altaf Individual · British · DOB 10/1999 · age 27 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 11/07/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A-ONE MEDIC LTD→ 08046419 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ALEXANDER SURGICAL LIMITED→ 12211188 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ALLEYNAGLYNE LTD→ 16215894 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ALPHA TRAINING LTD→ 15661039 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALR ASSETS LIMITED→ 13905313 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ALSTON LODGE COMMUNITY CARE LIMITED→ 11001919 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ALTASH HEALTHCARE LIMITED→ 08685250 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| AM OPTICAL LIMITED→ 07143998 · est 2010 · no financials extracted | — | — | — | — | 16y | — | — |
| AM PHARMA SERVICES LTD→ 16528953 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AME PHARMA LTD→ 16740079 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AMETHYST CLINIC LTD→ 15474030 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AMG SOLUTIONS LIMITED→ 16772249 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.